You are currently viewing Pharmatest receives approval of the French Tax Credit Incentive (Crédit d’Impôt Recherche CIR)

Pharmatest receives approval of the French Tax Credit Incentive (Crédit d’Impôt Recherche CIR)

Pharmatest has received the renewal of its French Tax Credit approval for the years 2024-2028.

What is French Tax Credit?

The French Tax Credit Incentive (Crédit d’Impôt Recherche CIR) is a tax relief for organizations based in France that outsource their Research & Development activities to third parties, such as Pharmatest. The incentive is up to 30% tax reduction of all Research & Development expenses.

The basis of eligibility for receiving the approval is conducting company’s own Research & Development studies and investment in Research & Development within the European Economic Area.

For more information on CIR benefits and filing, please visit the Ministry of Higher Education, Research and Innovation website.